IL-17 and IFN-gamma mediate the elicitation of contact hypersensitivity responses by different mechanisms and both are required for optimal responses.
IL-17 and IFN-gamma mediate the elicitation of contact hypersensitivity responses by different mechanisms and both are required for optimal responses.
复制标题
DOI:
10.4049/jimmunol.0804108
复制
发表时间:
2009-07-15
期刊:
影响因子:
--
通讯作者:
Xu H
中科院分区:
文献类型:
--
作者:
He D;Wu L;Kim HK;Li H;Elmets CA;Xu H
Hapten induced contact hypersensitivity (CHS) in the skin is a delayed type cellular immune response which can be mediated by CD8+ T cells that produce IFN-γ or IL-17. However, mechanisms for these cytokines in the elicitation of CHS remain to be fully elucidated. Here we show that adoptive transfer of CHS with hapten primed wild type CD8+ T cells is reduced in IFN-γR−/− or IL-17R−/− mice compared to wild type controls. The infiltration of granulocytes and macrophages in the hapten challenged skin of IL-17R−/− recipients is significantly reduced whereas it is less affected in IFN-γR−/− recipients although CD8+ T cell infiltration is inhibited in both recipients. In contrast, the activity of reactive oxidative species is significantly inhibited in IFN-γR−/− but is less affected in IL-17R−/− recipients. Further analysis reveals that the expression of chemokines and cytokines is differentially regulated in the hapten challenged skin of IFN-γR−/− or IL-17R−/− recipients compared to wild type controls. Interestingly, injection of recombinant IL-17 in the skin induces inflammation with a high level of leukocyte infiltration whereas injection of IFN-γ induces inflammation with a high level of reactive oxidative species. Moreover, neutralization of IL-17 in IFN-γR−/− or IFN-γ in IL-17R−/− mice further suppresses the adoptive transfer of CHS by hapten primed wild type CD8+ T cells. The study demonstrates that IFN-γ and IL-17 mediate the elicitation of CHS by different mechanisms and that both cytokines are required for optimal responses. This outcome improves understanding of pathogenesis and provides new insights into therapeutic strategies for CHS.
登录
查看更多内容
影响因子:
5.5
作者:
Engeman, T;Gorbachev, AV;Fairchid, RL
通讯作者:
Fairchid, RL
DOI:
10.1073/pnas.95.14.8233
发表时间:
1998-07-07
影响因子:
11.1
作者:
Lu, BF;Ebensperger, C;Rothman, PB
通讯作者:
Rothman, PB
影响因子:
56.9
作者:
HUANG, S;HENDRIKS, W;AGUET, M
通讯作者:
AGUET, M
影响因子:
14.2
作者:
Bellinghausen, I;Brand, U;Saloga, J
通讯作者:
Saloga, J
影响因子:
30.5
作者:
Hsu, Hui-Chen;Yang, PingAr;Mountz, John D.
通讯作者:
Mountz, John D.